Transcranial focused ultrasound stimulation of human primary visual cortex.
Authors: Lee W, Kim HC, Jung Y, Chung YA, Song IU, Lee JH, Yoo SS
Transcranial focused ultrasound (FUS) is making progress as a new non-invasive mode of regional brain stimulation. Current evidence of FUS-mediated neurostimulation for humans has been limited to the observation of subjective sensory manifestations and electrophysiological responses, thus warranting the identification of stimulated brain regions. Here, we report FUS sonication of the primary visual cortex (V1) in humans, resulting in elicited activation not only from the sonicated brain area, but also from the network of regions involved in visual and higher-order cognitive processes (as revealed by simultaneous acquisition of blood-oxygenation-level-dependent functional magnetic resonance imaging). Accompanying phosphene perception was also reported. The electroencephalo graphic (EEG) responses showed distinct peaks associated with the stimulation. None of the participants showed any adverse effects from the sonication based on neuroimaging and neurological examinations. Retrospective numerical simulation of the acoustic profile showed the presence of individual variability in terms of the location and intensity of the acoustic focus. With exquisite spatial selectivity and capability for depth penetration, FUS may confer a unique utility in providing non-invasive stimulation of region-specific brain circuits for neuroscientific and therapeutic applications.
Introduction
Purpose
Transcranial ultrasound stimulation
Study Objective
To test whether transcranial focused ultrasound targeting the human primary visual cortex can non-invasively elicit localized and network brain activation, measurable with simultaneous fMRI and EEG, and produce phosphene perception.
Disease model
healthy
MRI or image guidance method
MR-guided FUS using co-registered anatomical/functional MRI and cranial CT for sonication planning; high-resolution T1-weighted MR imaging was used to visualize the transducer, estimate the acoustic focus and beam orientation, and simultaneous BOLD-fMRI was acquired during sonication.
Targeted brain region(s)
V1
Outcomes and Safety
Summary of Outcomes
Transcranial FUS (270 kHz) targeting human V1 elicited localized BOLD-fMRI activation, EEG evoked potentials (N55/P100), and subjective phosphene perception.
Duration of biological effect
about 1 second
Safety-related matter
The procedure was safe with no abnormalities on post-sonication neurological exams or follow-up MRI (up to 2 months); exposure metrics remained strictly within FDA safety limits (MI 1.2).
Brain Region
Ultrasound Parameters
Ultrasound instrument
single-element focused ultrasound transducer
FUS Frequency
270 kHz
FUS Intensity
11.6 W/cm²
FUS Pressure
1.48 MPa
FUS Mode
pulsed
Pulse duration
1 ms
Duration of a single FUS session
300 ms
Treatment frequency
Single
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search